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OBJECTIVE—Women with gestational diabetes mellitus (GDM) show reduced insulin sen-
sitivity and markedly elevated glucose excursions. After delivery, GDM mostly reverts to normal
glucose tolerance (NGT), although leaving an increased risk of type 2 diabetes. Because gastro-
intestinal function changes during pregnancy causing vomiting, constipation, or reduced mo-
tility, we thought that gut glucose absorption in GDM or pregnancy might be altered to affect
circulating glucose excursions.
RESEARCHDESIGNANDMETHODS—Byundergoing180-minoralglucosetolerance
tests (OGTTs), pregnant women with GDM (GDMpreg; n =1 5 ,B M I=3 26 2k g / m
2,a g e d3 36 1
years) werecomparedwith NGTwomen(NGTpreg;n=7,B MI=2861kg /m
2,ag ed3462ye ar s) ,
matchingformajoranthropometriccharacteristics(eachP.0.2).Afterdelivery(6–7monthsla ter),
both groups were studied the same way. We computed and mathematically modeled gut glucose
absorption from insulin-mediated glucose disappearance and endogenous glucose production
(EGP). Whole-body insulin sensitivity was calculated using the Clamp-like Index.
RESULTS—GDMpreg showed 16–25% higher plasma glucose concentrations (P , 0.04) dur-
ing the ﬁnal 2 h of OGTT, similar EGP, but lower (P , 0.01) insulin sensitivity (2.7 6 0.2 mg z
kg
21zmin
21vs.NGTpreg:4.560.8mgzkg
21zmin
21).InGDMpreg,gutglucoseabsorptionrates
were #52% lower from 30 to 120 min (P , 0.03 vs. conditions after delivery or NGTpreg). In
contrast,glucoseabsorptionratesinNGTpregwerecomparableduringandafterpregnancy.None
of the studied women developed diabetes after delivery.
CONCLUSIONS—In GDMpreg, OGTT gut glucose absorption is markedly lower during
hyperglycemia, whereas both glycemia and glucose absorption in NGTpreg are comparable be-
tween pregnant and postpartum states. Thus, hyperglycemia in GDM does not seem to result
from too rapid or increased glucose absorption.
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W
omen with gestational diabetes
mellitus (GDM) display both im-
paired b-cell function and re-
duced sensitivity to insulin, bearing an
elevated risk to develop type 2 diabetes in
the future (1–3). Because GDM may result
in newborn macrosomia and other disor-
ders (4), the World Health Organization
and the International Association of
Diabetes and Pregnancy Study Groups
recommend the standardized, 75-g oral
glucose tolerance test (OGTT) at 24 weeks’
gestationor later to diagnose GDM (2). By
focusing on sex-related differences, we
have most recently investigated gut glu-
cose absorption by using 180-min OGTTs
in a healthy cohort of both sexes (5). We
found that women, when compared with
men, show differences in gut glucose ab-
sorption; intestinal uptake of glucose in
women is lower in the early phase but
higher in the late OGTT phase and may
also contribute to elevated OGTT glucose
concentrations in women at 120 min,
which several epidemiologic studies have
shown, as summarized in detail previ-
ously (5).
There is evidence that during preg-
nancy the function of the gastrointestinal
tract is altered; on the one hand, symp-
toms such as nausea, vomiting, and con-
stipation (6) occur, and on the other
hand, gastrointestinal transport and mo-
tility are diminished (6), most likely be-
cause of reduced endogenous prokinetic
peptiderelease(7).Thus,wehypothesized
that in pregnant women, when compared
with nonpregnant conditions, glucose ab-
sorption might be further decreased be-
cause of propulsion delay and could
therebyalsoaffectglucoseexcursions.Con-
versely, pronounced glucose excursions in
GDM might be the result of too rapid gas-
trointestinal transport/glucose absorption.
Thus, we aimed to compare glucose
absorption during 180-min OGTTs in
women during pregnancy and subse-
quently after delivery with 1)n o r m a lg l u -
cose tolerance (NGT) with women with
2) GDM, without differences in major an-
thropometric characteristics. We applied
our recently developed method that al-
lows estimation of glucose absorption
during OGTT without infusion of
(radio-)labeled isotopes (5).
RESEARCH DESIGN AND
METHODS
Study participants
Of those women participating in a pro-
spective longitudinal follow-up [Vienna
postgestationaldiabetesproject(8)],most
women were examined in a 120-min
OGTT (which is essential for GDM diag-
nosis), but a total of 22 women agreed
to undergo a 180-min OGTT at the end
of the second trimester and after delivery.
We only included those women who had
undergonea180-minOGTT,because ex-
amination during a 120-min OGTT
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ORIGINAL ARTICLEseemed not to be sufﬁcient to study the
entire glucose absorption process. The
pregnant study participants were divided
into two groups, depending on whether
they had NGT (“NGTpreg”)o rG D M
(“GDMpreg”)(2).Allsubjectswerestudied
againpostpartumusingthesameprotocol
(i.e., “NGT after delivery” and “former
GDM after delivery”) (Table 1). GDM and
diabetes (for the nonpregnant subjects)
were deﬁned as reported (2,9). All women
gave informed and written consent before
participating in the study.
75-g OGTT
Glucosetolerance was testedby an OGTT
(2,9,10) after ingestion of a 75-g glucose
solution (Gluco-Drink75, Roche Diag-
nostics, Vienna, Austria). Blood samples
for routine laboratory analysis were
drawn at baseline for determination of
plasmaglucose,seruminsulin,andserum
C-peptide at 0, 10, 20, 30, 60, 90, 120,
150, and 180 min and measured as de-
scribed (5,8,11). Plasma concentrations
of free fatty acids (FFAs) were measured
at fasting using a microﬂuorimetric assay
from Wako (Richmond, VA) (5).
Gut glucose absorption
Intestinal glucose absorption during OGTT
was calculated as recently described and
validated(5).TheClamp-likeIndex(CLIX),
whose values closely approach M-values
from the clamp test (10,12), was used for
insulin sensitivity measurement (13). In
brief, the increase of postprandial circulat-
ing glucose (dgluccirc)o v e rt i m e( d t )i st h e
result of gain from gut glucose absorption
(ABS)andEGP,andlossbecauseofglucose
uptake (Rd), predominantly by skeletal
muscle. Thus, changes in glucose concen-
tration over time can be expressed as
dgluccirc=dt ¼ 1=VG
3 ½BW 3 ðEGP 2 RdÞþABS  (1),
with initial condition: gluc(0) = fasting
glucose concentration; ABS(0) = 0; and
EGP(0) = Rd(0). BW is the body weight,
and VG is the oral glucose distribution
volume assumed as ;15% of BW (5). To
ensure that the glucose distribution vol-
ume is not different during pregnancy, we
carried out intravenous glucose tolerance
tests in pregnant GDM (n =7 ,B M I=
32 6 3k g / m
2), nonpregnant lean (n =5 ,
BMI = 23 6 1k g / m
2), and obese (n =
7, BMI = 35 6 2k g / m
2) women and
found no differences in the calculated VG
among those groups (data not shown).
We have most recently demonstrated
that EGP and Rd are predominantly regu-
lated by circulating insulin concentrations
(5).EGP inwomencanbecalculatedusing
the following relationship (5):
EGP ¼ 1:88920:342 3 ln½insulin  (2)
Rd was assessed by the logarithmic
relationship, on the one hand, between
fasting insulin concentrations and fast-
ing EGP that equals fasting Rd, and on the
other hand, between the CLIX and the
highest insulin concentration during
the OGTT, as described and used for
the validation group in the study by
Anderwald et al. (5).
For each participant, total glucose
absorbed was calculated by integrat-
ing glucose absorption rates over the
180-min OGTT. Glucose half-life in the
gastrointestinal tract was individually
determinedbylinearcurveinterpolation
of relative glucose retention during the
OGTT by using the closest time points
to cross the 50% threshold (5). Equa-
tion (1) was implemented using Matlab
(MathWorks Inc., Boston, MA), and gut
glucose absorption was modeled by
solving nonlinear least-squares prob-
lem ﬁtting the plasma glucose values
during the OGTT. Common criteria of
model performance (best ﬁt, residuals,
variance-covariance Fisher matrix) were
evaluated for accepting the ﬁnal model
prediction.
b-Cell function was assessed by the
Insulinogenic Index (IGI) for the ﬁrst
30 min of the OGTT, as described in de-
tail (14).
Statistical analyses
Before further analysis, normal distribu-
tion of the variables was tested by apply-
ing the Kolmogorov-Smirnov test for the
entire study population and each sub-
group separately (11). This test showed
that all of the continuous variables except
forserumtriglycerideswerenormallydis-
tributed. Therefore, serum triglycerides
were logarithmically transformed to
achieve normal distributions, and statis-
ticaltestswerethenapplied.Allnormally
distributed data are given as means 6
SEM; serum triglyceride concentrations
are given as median with interquartile
range. Intraindividual comparisons within
each group were analyzed with the paired,
two-tailed Student t test. Comparisons
b e t w e e nb o t hg r o u p sw e r ed o n ew i t h
the unpaired, two-tailed Student t test.
The nonparametric Kendall rank correla-
tion coefﬁcient was used for correlation
analysis.Differenceswereconsideredsta-
tistically signiﬁcant at P values # 0.05.
Table 1—Anthropometric and baseline laboratory measurements and 2-h post-OGTT
plasma glucose levels of the four groups consisting of women with NGT and GDM during
pregnancy and after delivery
NGT during
pregnancy
GDM during
pregnancy
NGT after
delivery
Former GDM
after delivery
N 71 5 7 1 5
Body height (cm) 168 6 21 6 2 6 21 6 8 6 21 6 2 6 2
Body weight (cm) 81.0 6 6.1 83.9 6 4.4 76.5 6 6.4# 79.7 6 4.7#
BMI (kg/m
2) 28.4 6 1.4 32.0 6 1.7 26.8 6 1.5# 30.3 6 1.7#
Age (years) 34 6 23 3 6 13 4 6 2# 34 6 1#
Serum creatinine (mg/dL) 0.64 6 0.03 0.58 6 0.03 0.80 6 0.07# 0.75 6 0.04 #
Serum triglycerides (mg/dL) 252 (101) 161 (65) 79 (111)# 85 (92)#
Serum cholesterol (mg/dL) 261 6 17 235 6 14 193 6 9# 218 6 18
Serum HDL cholesterol (mg/dL) 83 6 11 69 6 46 1 6 46 0 6 5#
HbA1c (%) 5.1 6 0.1 5.2 6 0.1 5.5 6 0.2# 5.5 6 0.1#
FFAs (mmol/L) 424 6 52 566 6 36* 434 6 72 612 6 44*
Gestational week 27.1 6 0.7 25.5 6 0.4* ——
OGTT
Fasting glucose (mg/dL) 83 6 29 1 6 39 3 6 3# 94 6 3
1-h Post-OGTT plasma
glucose (mg/dL) 159 6 71 9 4 6 4* 161 6 19 171 6 8#
2-h Post-OGTT plasma
glucose (mg/dL) 127 6 61 5 2 6 6* 126 6 14 122 6 9#
Data are given as means 6 SE except for triglycerides: median (interquartile range); paired Student t test for
intraindividual analyses,unpairedStudentttestforNGTvs.GDMduringpregnancy and afterdelivery.*P,
0.04 GDM vs. NGT. #P , 0.02 after vs. during pregnancy.
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Anthropometry and basal routine
laboratory measurements
Of the 22 pregnant women undergoing a
180-min OGTT, 7 and 15 subjects had
NGT and GDM, respectively. GDMpreg
and NGTpreg had comparable BMI and
age as major anthropometric characteris-
tics, as well as serum concentrations of
creatinine, total and HDL cholesterol,
and glycated hemoglobin A1C (HbA1c).
Serum triglycerides were not different
between the groups and decreased after
giving delivery in GDM and NGT (each
P , 0.01). During and after pregnancy,
GDM had higher fasting (each P , 0.04)
plasma FFA than NGT. With regard to
gestationalage,GDMpregwerestudiedap-
proximately 12 days earlier (P , 0.04)
than NGTpreg (Table 1).
After delivery, both groups were sim-
ilar in BMI, age, and levels of creatinine,
lipids, and HbA1c. However, when com-
paring both NGT and GDM after delivery
with conditions during pregnancy, BMI
and serum lipids decreased, whereas se-
rumcreatinineandHbA1cincreased(each
P , 0.02).
75-g OGTT
In NGT, fasting plasma glucose after de-
livery was 12% higher (P , 0.02) (Fig. 1A,
Table 1). Plasma glucose was lower at
10 min in GDMpreg (P , 0.01 vs. after
delivery), but thereafter increased in
GDMpreg in the 2nd h, when compared
with NGTpreg (each P , 0.03), and dur-
ing the ﬁnal 2 h, when compared with
conditionsafterdelivery(eachP , 0.04)
(Fig. 1A). Serum insulin concentrations
were elevated in GDMpreg at 180 min,
when compared with NGTpreg (P , 0.03),
and at 60 min and from 120 to 180 min in
comparison with postpartum conditions
(eachP,0.04)(Fig.1B).SerumC-peptide
was higher in the 3rd OGTT h in GDMpreg
(P , 0.04 vs. after delivery or NGTpreg),
whereas the other groups displayed a sim-
ilar time course of C-peptide (Fig. 1C). Af-
ter delivery, none of the former GDM or
NGT women developed diabetes, as con-
ﬁrmed by the OGTT.
Whole-body insulin sensitivity
TheGDMpreghada40%lower(P,0.01)
CLIX than the NGTpreg. However, after
delivery, insulin sensitivity improved
in the women with former GDM (P ,
0.001) and was similar to that in women
with NGT after delivery. Insulin sensitiv-
ity in women with NGT was comparable
Figure 1—Circulating concentrations of (A)g l u c o s e ,( B) insulin, and (C) C-peptide, as well as
(D)theCLIX,(E)correlation(t =20.206,P,0.05)oftheCLIXwiththeIGI,(F)EGP,and(G)
gut glucose absorption in pregnant women with NGT during pregnancy (●, n =7 )o rG D M( ■,
n = 15), all of whom were studied again under identical conditions after delivery: NGT (○)a n d
former GDM (□). Unpaired Student t test: ⋆P , 0.03 GDM vs. NGT during pregnancy; paired
Student t test: #P , 0.05 GDM during pregnancy vs. after delivery, $P , 0.02 NGT during
pregnancy vs. after delivery.
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(Fig. 1D).
b-Cell function
IGI in NGTpreg (0.419 6 0.070) was sim-
ilar to that in GDMpreg (0.536 6 0.070),
in whom IGI decreased (P , 0.04) after
delivery (0.391 6 0.053) and was then
comparable to NGT after giving birth
(0.389 6 0.065). Figure 1E displays the
inverse relationship between b-cell func-
tion and insulin sensitivity (t = 20.206,
P , 0.05).
Endogenous glucose production
All four groups showed similar endoge-
nous glucose production (EGP) both at
fasting and during OGTT (Fig. 1F).
Gut glucose absorption
TheGDMpregshowedmarkedlylowergut
glucose absorption rates than NGTpreg
(60–120 min, each P , 0.03) and when
compared with conditions after delivery
(20–120 min, each P , 0.03) (Fig. 1G).
Gut absorption in women with NGT dur-
ing pregnancy did not change after de-
livery. Total glucose absorbed during
180-min OGTT was lower in GDMpreg
(31 6 2 g), when compared with condi-
tionsafterdelivery(4766g,P,0.01)or
NGTpreg(4365g,P,0.02),whosetotal
glucose amount absorbed did not change
aftergivingbirth(4665g).Glucosehalf-
lifeinthegastrointestinaltractwassimilar
in all four groups (GDMpreg:7 66 3m i n ,
NGTpreg:7 66 5 min, former GDM after
delivery: 73 6 4 min, NGT after delivery
71 6 5m i n ;e a c hP . 0.25) and nega-
tively correlated with body height (t =
20.288, P , 0.01), but not BMI.
To compensate for differences in
body mass (nonsigniﬁcant) and gesta-
tional age, we performed a precise pair-
match (seven control subjects with seven
GDM subjects). The analysis yielded that
the results remained almost the same
regarding the study’s main focus (i.e.,
gut glucose absorption; data not shown).
CONCLUSIONS—The current study
investigated whether 1)g u tg l u c o s ea b -
sorption is altered during pregnancy and
2) GDM is the result of elevated or accel-
erated gastrointestinalabsorption.Tothis
end, we performed OGTTs in 22 preg-
nant women (15 with GDM and 7 with
NGT) and repeated the procedure ;3
months after delivery. We also assessed
whole-body insulin sensitivity and b-cell
function. Our novel, noninvasive model-
ing approach allowed us to calculate both
EGP and gut glucose absorption in preg-
nant women, which to the best of our
knowledge has never been done before.
This study’sm a i nﬁndings are 1)
GDMpreg show pronounced insulin resis-
tance, compared with NGTpreg and con-
ditions after delivery, when they show a
nondiabeticglucosemetabolism;2)b-cell
function is increased in GDMpreg and
inversely relates to whole-body insulin
sensitivity in all subjects; 3) fasting and
post glucose-load EGP are comparable
in all groups; and 4) gut glucose absorp-
tion is reduced in GDMpreg but normal-
izes after delivery.
Whole-body insulin sensitivity and
b-cell function
It has been known for a while that
pregnancy has the potential to induce
pronounced insulin resistance (15). In
our study participants, the GDMpreg
were more insulin resistant than the
NGTpreg, which is in line with previous
reports (15). Low insulin sensitivity is
also associated with increased lipid avail-
ability(11),especiallyelevatedcirculating
FFAs, which were actually higher in the
GDMpreg.
In the presence of insulin resistance,
the b-cells attempt to compensate by
increasing insulin release, aiming to
maintain a normal glucose metabolism,
also during a glucose challenge. Despite
increased insulin secretion, the GDMpreg
were not able to keep OGTT glucose con-
centrations within the nondiabetic range.
Thus, the increase in b-cell function was
at least in part insufﬁcient to compensate
for that pronounced degree of insulin re-
sistance in the GDMpreg.O u rﬁndings of
an inverse relationship between b-cell
function and whole-body insulin sensi-
tivity have already been discussed by
Buchanan (15) and are therefore com-
pletely in agreement.
Endogenous glucose production
Our mathematic modeling allows for
calculation of EGP during an OGTT,
as validated by the gold standard, the
double-tracertechnique(5).Inthisstudy,
we found that EGP does not change dur-
ing pregnancy, regardless of the presence
of GDM or NGT. However, it should be
added that in diabetes, the increase in
fasting glucose is the result of elevated
EGP(16).FastingglucoseinourGDMpreg
was on average comparable to that post-
partum andthat inNGTpreg.Thus,itdoes
not seem surprising that fasting EGP
was not elevated in GDMpreg. However,
it cannot be ruled out that in a GDM co-
hort with markedly elevated fasting glu-
cose concentrations, EGP would be
increased as well.
Inaddition,Catalanoetal.(17)inves-
tigated EGP in women during and after
pregnancy and found that, regardless of
NGTorGDMpresence,basalEGPinearly
pregnancy (12–14 weeks) was similar to
that in nonpregnant conditions. How-
ever, in late pregnancy (34–36 weeks),
basal EGP was higher. Suppression of
EGP by insulin was also similar in non-
pregnantconditionsand earlypregnancy,
again regardless of NGT or GDM pres-
ence. The women in our study were in
the 26–27th week of pregnancy, thus
just in the middle between early and late
pregnancy.Bycombiningourcurrentand
previous (17) observations, it seems that
(basal) EGP during pregnancy does not
increase until the very late period.
Gut glucose absorption
In GDMpreg, gut glucose absorption was
markedly reduced by up to ;50% from
30 to 120 min, when compared with
postpartum conditions or the NGTpreg
group (60–120 min; Fig. 1G). In NGT
during and after pregnancy, and the
GDM postpartum group, approximately
two-thirds of the entire glucose load
could be found in the circulation. This is
not surprising because a substantial part
of the entire load is thought to escape
absorption (5,18). In contrast, in the
GDMpreg less than one-half of the total
glucose ingested appeared in the blood-
stream within the ﬁr s t3h .G u tg l u c o s e
half-lifewas similarinallgroups,suggest-
ing that the absorption process in
GDMpreg was somewhat reduced as a
whole.
Possible mechanisms
Orocecal transit time increases in the
course of pregnancy (6), but gastric emp-
tying remains unaffected in the second or
third trimester of pregnancy (19,20). In
addition, the gastrointestinal smooth-
muscle stimulating hormone motilin is
lower in pregnant women (7). On the
other hand, hyperglycemia and hyper-
insulinemia also reduce gastrointestinal
motility and transit time in healthy hu-
mans (21,22). Thus, gut glucose absorp-
tion in type 2 diabetic and critically ill
patients with hyperglycemia is dimin-
ished (23,24). Taken together, the lower
glucose absorption rates found inGDMpreg
seem understandable and might be due to
1) hyperglycemia, 2) hyperinsulinemia,
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during pregnancy. It should be considered
that women with NGT had similar gut ab-
sorption rates during and after pregnancy
(Fig. 1G); thus, the effect by reduced pro-
kinetic motilin seems minor. However, it
cannot be ruled out that the combination
ofhyperglycemia,hyperinsulinemia,andre-
duced motilin per se exerted a much greater
effect in GDM than each of them solely.
Clinical relevance
Our study demonstrates that gut glucose
absorption is lower in GDMpreg, inpartic-
ular during their greatest glucose excur-
sions (60–120 min); thus, hyperglycemia
in GDM seems not to be due to increased
or too rapid glucose absorption, but
rather to pronounced insulin resistance
and the failure of b-cells to fully compen-
sate.
Limitations
Glucose absorption rates at 180 min were
small, but still existent, with ;0.15–0.18
g/min. Thus, in the 4th h after glucose
ingestion, a small proportion (#10 g) of
the glucose load is expected to be ab-
sorbed as well, which could have been
seen during a prolonged designed exam-
ination period.
The studied sample size was rather
small, which is in part due to strict
legislature and other ethics guidelines
for studies in pregnant women. Of note,
several other interesting investigations
(6,17,19) have therefore included only
between one and two dozen women. In
addition, gestational age was statistically
different between the two pregnant
groups. This can be explained in that all
pregnant women were asked to partici-
pate between the 24th and 28th gesta-
tional week. Most likely by chance, the
GDM were studied a few days earlier,
which, however, turned out to be statisti-
cally signiﬁcant (Table 1). When looking
at a precise pair-match, in which the ges-
tational age was similar, the main read-
outs remained nearly identical to these
presented; thus, we conclude that the im-
pact of different gestational age might be
negligible.
Major conclusion
In GDMpreg, gut glucose absorption dur-
ing an OGTT is markedly lower despite
marked hyperglycemia, whereas NGT
women show no differences in both gly-
cemia and gastrointestinal glucose ab-
sorption when comparing conditions
during pregnancy with those after delivery.
Thus, hyperglycemia in GDM does not
seem to result from a too rapid or increased
gastrointestinal glucose absorption.
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